Global Wealth Strategies & Associates’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-29
Closed -$4.07K 224
2026
Q1
$4.07K Sell
29
-20
-41% -$2.8K ﹤0.01% 369
2025
Q4
$6.01K Sell
49
-1
-2% -$122 ﹤0.01% 352
2025
Q3
$5.55K Buy
50
+31
+163% +$3.52K ﹤0.01% 331
2025
Q2
$2.11K Hold
19
﹤0.01% 308
2025
Q1
$2.13K Hold
19
﹤0.01% 379
2024
Q4
$1.75K Hold
19
﹤0.01% 331
2024
Q3
$1.59K Hold
19
﹤0.01% 307
2024
Q2
$1.3K Hold
19
﹤0.01% 281
2024
Q1
$1.39K Sell
19
-1
-5% -$77 ﹤0.01% 296
2023
Q4
$1.58K Sell
20
-11
-35% -$856 ﹤0.01% 261
2023
Q3
$2.29K Buy
31
+12
+63% +$923 ﹤0.01% 259
2023
Q2
$1.46K Hold
19
﹤0.01% 267
2023
Q1
$1.58K Sell
19
-100
-84% -$8.28K ﹤0.01% 279
2022
Q4
$10.2K Buy
+119
New +$9.42K 0.01% 147

Other funds holding GILD

Global Wealth Strategies & Associates's GILD Position: Q2 2026 in Review

Global Wealth Strategies & Associates sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 29 shares — an estimated $4.07K sold.

Global Wealth Strategies & Associates first reported a position in GILD in Q4 2022 and held it in 14 quarters. The position peaked at $10.2K in Q4 2022. 1,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Global Wealth Strategies & Associates reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
  • Global Wealth Strategies & Associates sold 29 Gilead Sciences shares in Q2 2026, an estimated $4.07K.
  • Global Wealth Strategies & Associates first reported a position in Gilead Sciences in Q4 2022 and held it in 14 quarters.
  • Global Wealth Strategies & Associates's Gilead Sciences position peaked at $10.2K in Q4 2022.
  • 1,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Global Wealth Strategies & Associates's 13F filing for Q2 2026, filed 1 Jul 2026.